MedTrace Logo

Point of Care STI Testing

NCT06844045 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6460

Last updated 2026-05-05

No results posted yet for this study

Summary

The proposed research hypothesizes that point-of-care testing (POCT) for sexually transmitted infections (STIs) gonorrhea and chlamydia will be a feasible, acceptable, and appropriate implementation strategy for improving HIV testing and Pre-exposure prophylaxis (PrEP) delivery in youth, by increasing opportunities for clinician-patient counseling, decreasing loss to follow up, and allowing for same-day HIV prevention service provision. This hypothesis will be tested in a pragmatic non-randomized trial comparing clinical (HIV testing and PrEP counseling and prescription) and implementation (feasibility, acceptability, and appropriateness) outcomes between adolescents receiving POCT compared to laboratory-based testing at three clinics within a large pediatric health system.

Conditions

  • Point of Care STI Testing

Interventions

BEHAVIORAL

Gonorrhea/chlamydia Point-of-Care Testing

Point-of-care testing for sexually transmitted infections.

Sponsors & Collaborators

Principal Investigators

  • Sarah Wood, MD, MSHP · Mount Sinai Adolescent Health Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
24 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-24
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06844045 on ClinicalTrials.gov